-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Radiprodil in Neurodegenerative Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Radiprodil in Neurodegenerative Diseases report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Radiprodil in Neurodegenerative Diseases Drug Details: Radiprodil is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – C-106 in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - C-106 in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.C-106 in Idiopathic Pulmonary Fibrosis Drug Details:C-106 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Catequentinib Hydrochloride in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Catequentinib Hydrochloride in Metastatic Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Catequentinib Hydrochloride in Metastatic Colorectal Cancer Drug Details: Catequentinib hydrochloride...